Sinofn Health
In the nutraceutical landscape, the debate between Ubiquinol (the reduced form) and Ubiquinone (the oxidized form) is a hallmark of sophisticated formulation science. As a premier OEM/ODM manufacturer, SINOFN Health bridges this gap by providing high-purity, bioavailability-optimized raw materials that cater to the evolving needs of the aging population and performance athletes.
Ubiquinone (CoQ10) is the oxidized version commonly found in many legacy supplements. However, human cellular absorption processes must convert CoQ10 into Ubiquinol to be utilized in mitochondrial ATP production. For demographics with compromised metabolic pathways or advanced age, this endogenous conversion efficiency significantly drops. Our manufacturing protocols prioritize stable Ubiquinol production, ensuring the active form is delivered directly for superior bioavailability.
Ubiquinol is notoriously sensitive to oxygen and light. Our R&D team, led by Dr. Zhang Ying and Dr. Tan Shengjie, has developed proprietary stabilization techniques, utilizing advanced softgel encapsulation and micro-emulsification, to protect the delicate structure of Ubiquinol. This ensures that the product delivered to the end consumer retains its potency from factory to shelf.
Global procurement requires more than just high-quality ingredients; it requires strict adherence to international standards. Whether you are targeting the FDA (US), EFSA (EU), or regional Asian markets, SINOFN provides:
Leveraging deep industrial integration with the Chinese Academy of Sciences (CAS), we offer cost-efficiency without compromising quality. Our 53,000 sqm facility isn't just a factory; it's a hub of innovation where "Scale-Up" is handled via pilot-scale prototyping, reducing time-to-market for global brands.
Our team, including experts from the Chinese Academy of Sciences and Peking University Medical School, ensures that every OEM project—from Ubiquinol supplements to complex functional beverages—is built on a foundation of peer-reviewed science.
Suppliers without R&D are "transactors," whereas those with R&D are "partners." We provide custom formulation, stability optimization, and regulatory filing support, ensuring your product doesn't just launch, but succeeds in the market.
We operate with a "Local-for-Local" mindset. By understanding the specific dietary and regulatory hurdles of regions like the EU (REACH compliance) and the US (GMP/NSF), we customize the manufacturing process at the formulation stage, preventing costly re-labeling or product rejection at the border.
Yes. Our R&D center is equipped with pilot-scale manufacturing lines specifically designed for testing formulations before full-scale production, minimizing your financial risk and accelerating your "Go-to-Market" strategy.